Atlas Trials

S0802 - Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Clinical trial NCT00828139 · COMPLETED

Trial details

NCT number
NCT00828139
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Extensive Stage Small Cell Lung CancerRecurrent Small Cell Lung Cancer
Start date
2009-05-01
Primary completion
2012-09-01
Enrollment
189

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.